
Opinion|Videos|October 24, 2024
Effective Balance of Approved Therapies and Patient Preferences
Author(s)Stuart H. Isaacson, MD, FAAN
Key Takeaways
- Patient-centered care involves understanding patient values and preferences alongside clinical efficacy and safety of therapies.
- Open communication and shared decision-making empower patients to actively participate in their treatment plans.
Dr. Isaacson discusses how health care providers can effectively balance the pharmacological properties of approved therapies for Parkinson's disease with patient preferences and comfort levels by fostering open communication and individualized care approaches.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can healthcare providers effectively balance pharmacological properties of approved therapies with patient preferences and comfort levels?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players
2
American Academy of Neurology, American Headache Society Issue Updated Guideline on Migraine Prevention
3
EU Approves Modified-Release Carbidopa/Levodopa Capsules for Parkinson Disease Motor Fluctuations
4
uniQure Submits BLA for Gene Therapy in Huntington Disease
5






